A surgeon and Research Director for the Division of Abdominal Organ Transplantation, Dr. Emamaullee is taking a high-tech approach to challenge that status quo.
Michael joined the Single Cell, Sequencing, and CyTOF (SC2) Core in 2018. In his role, he assists scientists in identifying and quantifying various biomarkers in tissue and liquid biopsy samples.
Researchers are searching for biomarkers to better identify which children with acute liver failure will recover on their own—and which will need a liver transplant.
CHLA core facilities share a common theme: The staff pride themselves on providing leading-edge technology, but they are also truly invested in the experiments and the scientists themselves.